Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Hollandia
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Rotterdam
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 3. fázisNot yet taking people in HollandiaRollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.
- Where
- Rotterdam
- People
- 340 worldwide
- Run by
- AstraZeneca AB
See details and how to join2026-526419-13-00 - 2. fázisTaking peopleEvaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Mediar Therapeutics Inc.
See details and how to join2025-523288-39-00 - 3. fázisTaking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Groningen, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - 1. fázisNot yet taking people in HollandiaA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Amsterdam, Leiden
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - 2. fázisTaking peopleEncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Mediar Therapeutics
See details and how to joinNCT07287670 - 1/2. fázisTaking peopleT-Guard in dcSSc
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 13
- Run by
- Philikos B.V.
See details and how to join2024-517283-28-00 - 2. fázisTaking peoplePlatform Clinical Study for Conquering Scleroderma
- Where
- Groningen, Leiden, Utrecht
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Scleroderma Research Foundation, Inc.
See details and how to joinNCT06195072 · EU 2023-507129-40-00 - 2. fázisTaking peopleFibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 60
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-522834-30-01 - 4. fázisTaking peopleEfficacy and safety of repeated Rituximab infusions in patients with Active Systemic SClerosis and background medication, a one year randomized blinded placebo-controlled trial, the RASSc study.
- Where
- Leiden, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 105
- Run by
- Radboud universitair medisch centrum Stichting
See details and how to join2025-520483-17-01 - 1/2. fázisTaking peopleMesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 20
- Run by
- UMC Utrecht
See details and how to joinNCT03211793 · EU 2024-515387-31-00 - 4. fázisNot yet taking people in HollandiaInvestigating the (autoreactive) B cell compartment in antibody-mediated autoimmune diseases in comparison with the recall Tetanus Toxoid response
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 96
- Run by
- Leids Universitair Medisch Centrum (LUMC)
See details and how to join2024-515312-50-00 - No phaseTaking peopleHand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 300
- Run by
- UMC Utrecht
See details and how to joinNCT06133244